SYNERGISTIC COMPOSITION COMPRISING SULFONYLUREA AND/OR NONSULFONYLUREA K+ATP CHANNEL BLOCKER AND PHOSPHODIESTERASE 3 TYPE INHIBITOR

Japanese Patent JP2001354568

A

To provide an improved method for treatment of noninsulin dependent diabetes and the like by using synergistic amounts of (1) sulfonylurea, nonsulfonylurea K+ATP channel blocker or sulfonylurea and nonsulfonylurea K+ATP channel blocker and (2) cAMP phosphodiesterase 3 type inhibitor.

This method for treatment of non-insulin dependent diabetes comprises administrating synergistic amounts of (1) sulfonylurea, nonsulfonylurea K+ATP channel blocker or sulfonylurea and nonsulfonylurea K+ATP channel blocker and (2) phosphodiesterase 3 type inhibitor to a patient infected or at risk for noninsulin dependent diabetes.

FRYBURG DAVID ALBERT
PARKER JANICE CATHERINE

JP2001115674A

December 25, 2001

April 13, 2001

Click for automatic bibliography generation  

PFIZER PROD INC

A61K31/133; A61K31/137; A61K31/155; A61K31/216; A61K31/336; A61K31/4015; A61K31/403; A61K31/407; A61K31/4174; A61K31/4178; A61K31/427; A61K31/437; A61K31/4427; A61K31/444; A61K31/445; A61K31/4545; A61K31/4704; A61K31/496; A61K31/4965; A61K31/50; A61K31/501; A61K31/519; A61K31/5377; A61K31/538; A61K31/618; A61K31/64; A61K31/7036; A61K31/7042; A61K38/28; A61K45/06; A61P3/08; A61P3/10; A61K45/00; A61P43/00; (IPC1-7): A61K31/64; A61K31/133; A61K31/137; A61K31/155; A61K31/216; A61K31/336; A61K31/4015; A61K31/403; A61K31/407; A61K31/4174; A61K31/4178; A61K31/427; A61K31/437; A61K31/4427; A61K31/444; A61K31/445; A61K31/4704; A61K31/496; A61K31/4965; A61K31/50; A61K31/501; A61K31/519; A61K31/5377; A61K31/538; A61K31/618; A61K31/7036; A61K31/7042; A61K38/28; A61K45/00; A61K45/06; A61P3/08; A61P43/00

Kazuo Shamoto (5 outside)

Previous Patent: REMEDY FOR DERMATITIS

Next Patent: COMPLEX OF IN VIVO STABLE POLYMER AND POLYNUCLEOTIDE FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS